New York Genome Center

The State of CRISPR and Genome Editing In The State of CRISPR and Genome Editing virtual summit, GEN brings together an outstanding line-up of pioneers and practitioners in genome editing to provide a compelling and candid overview of the field.

Weill Cornell and NYGC study reveals new method for cancer detection The research partially received support from the National Cancer Institute.

New York Genome Center Receives $125 Million to Continue Operations Plus, the 1803 Fund pledged $75 million to Oregon groups that serve Black youths, and the Bezos Earth Fund and the Global Methane Hub will give $27.4 million to lower methane emissions through livestock breeding programs.

Paired-Damage-seq - single-cell parallel analysis of DNA damage and transcriptome Researchers have developed Paired-Damage-seq, a method combining single-cell RNA sequencing with DNA damage analysis to reveal genome vulnerabilities linked to disease risk...

For decades, government funding “has positioned the United States as a global leader” in science, says scientist Tom Maniatis of Columbia’s Zuckerman Institute and the New York Genome Center. He highlights how a new National Institutes of Health policy cutting money for research “jeopardizes” this, in Cell: https://tinyurl.com/ubw6uphe

See our related animation on these NIH funds: https://youtu.be/DawuYYRSAgE?si=t53swV7GovsCl-px

NIH's new policy (NOT-OD-25-068) capping indirect cost reimbursement at 15% threatens the future of research, training, and scientific infrastructure at research institutions nationwide. In response, the NYGC has drafted a petition urging its reversal.

Please join us by signing and circulating this petition within your networks.

Sign the Petition Petition to Reverse the NIH Indirect Cost Cap (NOT-OD-25-068)

How genes are mapping the way to cancer cures Genes are mapping the way to cancer cures.

Why tumour geography matters — and how to map it Methods for exploring the geography of molecular-scale processes within tissue samples are transforming cancer research, but the toolbox can be daunting.

Novel CRISPR Technique Holds Promise for Bespoke Cancer Treatment A new type of CRISPR gene-editing technology has revealed the crucial cellular functions of noncoding RNAs, once considered genetic junk, and suggests they could be useful targets for personalized cancer treatments.

Breakthrough Study Reveals How Bladder Cancer Starts and Spreads Researchers found that DNA mutations from antiviral enzymes and chemotherapy fuel early bladder cancer, while abnormal circular DNA in tumor cells drives resistance to therapy. These discoveries open new therapeutic avenues. A groundbreaking study led by researchers at Weill Cornell Medicine and

Privacy concerns in RNA sequencing - new method quantifies single-cell data’s risk of private information leakage Privacy concerns in RNA sequencing - new method quantifies single-cell data’s risk of private information leakage